AMR-Targeting Drug Secures EMA PRIME Designation

 
• By Neena Brizmohun
  
Antimicrobial Resistance and bacteria changing over time and no longer responding to medicines
MEM-ANT3310 is a next-generation, broad-spectrum antibacterial (Shutterstock)

More from Review Pathways

More from R&D